Related Experiment Video
Updated: May 21, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Recent progress in structure-based anti-influenza drug design.
Juan Du1, Timothy A Cross, Huan-Xiang Zhou
1Department of Physics, Florida State University, Tallahassee, FL 32306, USA.
Drug Discovery Today
|June 19, 2012
Summary
This review covers structure-based drug design for influenza, focusing on computational methods to combat drug resistance in seasonal and pandemic strains like H5N1 and H1N1.
Area of Science:
- Virology and Drug Discovery
- Computational Chemistry and Structural Biology
Background:
- Influenza viruses cause significant global morbidity and mortality.
- Emerging strains like H5N1 and H1N1 raise concerns due to drug resistance.
- Viral proteins are key targets for anti-influenza therapeutics.
Purpose of the Study:
- To review recent advancements in structure-based anti-influenza drug design.
- To highlight the growing importance of computational approaches.
- To discuss strategies for overcoming drug resistance.
Main Methods:
- Review of current literature on structure-based drug design for influenza.
- Analysis of computational methods applied to anti-influenza drug discovery.
- Examination of resistance mechanisms and strategies to counter them.
Main Results:
- Significant progress has been made in identifying and targeting viral proteins.
- Computational tools are increasingly vital in accelerating drug design.
- Novel strategies are emerging to address and overcome influenza drug resistance.
Conclusions:
- Structure-based design, enhanced by computation, offers promising avenues for new influenza therapies.
- Addressing drug resistance is critical for effective pandemic preparedness.
- Continued research is needed to develop robust anti-influenza treatments.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...